Speaking at the 11th Tumor Models Summit San Francisco

8:00 am - Wednesday 10th February 2027

Speakers:

Christopher Szeto
Senior Director, Discovery Bioinformatics
Exelixis, Inc.
Barbara Sennino
Senior Vice President & Head of Early Development
3T Biosciences
Mat Sowa
Vice President, Lead Discovery
C4 Therapeutics Inc
Kan Lu
Senior Director - Biology
Apeximmune Therapeutics Inc.
Pamela Contag
President & Chief Executive Officer
Bioeclipse Therapeutics
Kate Rochlin
President & Chief Operating Officer
IN8Bio
Edgar Rodriguez
Chief Executive Officer
iOncologi
John Wang
Chief Scientific Officer
Kali Therapeutics
Igor Nasonkin
Co-Founder & Chief Executive Officer
Phythera Therapeutics
Michael Winter
Vice President of Platform Biology & Translational Sciences
Ridge Biotechnologies, Inc.
Nicholas Frankel
Director of Research
Senti Biosciences Inc.
Srivatsan Kidambi
Scientific Director, NIH SOM Initiative
NIH
Colin Flaveny
Senior Director
Pfizer
Vanessa Braunstein
Senior Director - TuneLab Artificial Intelligence, Drug Discovery Platform & Ecosystem Growth
Eli Lilly & Co.
Jorge Benitez
Senior Principal Scientist
Bristol Myers Squibb
Ernesto Diaz Flores
Lead/Director - Cancer Biology Research & Therapeutics
Astellas Pharma
Jessica Orf
Director
Gilead Sciences
Deepali Sawant
Scientific Associate Director
Amgen Inc.
Poonam Yakkundi
Associate Director - Pharmacology
Synthetic Design Lab
Ana Krtolica
Chief Development Officer
Swiss Rockets AG
Nathan Mathewson
Director, Immune Targeting
Vir Biotechnology Inc.
Genevive Hernandez
Executive Director, Biomarker Research & Translational Science
Sutro Biopharma
Jay Batchu
Senior Associate & Entrepreneur in Residence
Xontogeny